05012025
Last update: 04/29/2025 9:04

Videonews

 
Meet the Joint Lab CSIC - ALBA for the energy transition

Most read

CSIC spin- off will develop flexible carbon-based chips for monitoring sensors
New gluten-degrading protein could allow better management of coeliac disease
Deciphering how bacterial cellulose promotes plant tissue regeneration
Innovation in the advanced production of semiconductor qubits for quantum computing

Newsletter

Here you may suscribe to the ENGLISH version of our newsletter. Please, tell us your field of business or interest, and your email adress:

Graphene-based biosensor enables ultra-sensitive detection of hepatitis C virus

Technological offers
An international team with CSIC participation has successfully developed and validated a biosensor for the ultra-sensitive detection of the hepatitis C virus (HCV). The device is based on graphene transistors that can detect key proteins of the virus. The results of this research appear in the journal Biosensors and Bioelectronics and the scientific team has already applied for the international patent of the invention.

Three epigenetic biomarkers of thyroid cancer identified to facilitate diagnosis

Technological offers
A team from CSIC and the FINBA Foundation has identified three biomarkers that predict with high specificity and sensitivity the malignancy of a thyroid nodule, which could avoid many unnecessary surgeries. They are now looking for interested companies to develop specific kits.

New drug composition for uveal melanoma developed

Technological offers
CSIC has developed a pharmaceutical composition to treat uveal melanoma, a cancer that forms from melanin-producing cells in the eye. Although it has a low incidence, it is the most common eye cancer in adults. There are a few standard treatments for the primary tumour, but not for metastatic uveal melanoma of the eye.

Scientists develop the first portable magnetic resonance device

Technological offers
A team from the Institute of Instrumentation for Molecular Imaging (i3M), a joint centre of the CSIC and the Polytechnic University of Valencia, has developed the first portable magnetic resonance imaging. It is a low-cost device that can be used in situations where this diagnostic technique is usually ruled out for technical or economical reasons.

FlyGear, a robotic device for monitoring insects automatically and accurately

Technological offers
The CSIC and the Miguel Hernández University have developed a robot and its software for counting and measuring, in an automated, precise and reliable way, the transition time between life stages of fruit flies and other insects.

A biomarker signature for predicting response to cancer immunotherapy

Technological offers
The CSIC has developed, together with other institutions, a method to personalise therapeutic strategies combined with immune checkpoint inhibitors (ICIs) in cancer patients. It is based on 10 biomarkers, and facilitates the optimisation of therapeutic strategies for various types of tumours.

Patented molecules that counteract the effect of the most common anticoagulant drug

Technological offers
Researchers at IQAC-CSIC have successfully tested molecules that reverse the effect of the anticoagulant heparin, used to treat patients at risk of thrombosis. These new molecules have been patented. Patients treated with heparin may need to block its effect during surgery. The only drug available nowadays has a high molecular weight and may have associated side effects.

Miniaturized device for electrical stimulation of cell cultures

Technological offers
The use of electrical stimulation in medical research is growing rapidly for its effects on cell regeneration. The CSIC, the Autonomous University of Madrid and the University of Florida have developed a miniaturised device for in vitro electrical stimulation of cells and tissues. The technology is available for further development and commercialization.

DNA probes for the fast detection of SARS-CoV2 and influenza virus

Technological offers
Scientists from the CSIC, the University of Barcelona and the CIBER network laboratory have developed DNA probes for the fast detection of respiratory disease viruses, including SARS-CoV2 and influenza. The technology is available for further development through agreements with industry partners.